Decreased CXCL12 (SDF-1) Plasma Levels in Early Alzheimer's Disease: A Contribution to a Deficient Hematopoietic Brain Support?
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The chemokine CXCL12 (also known as stromal cell-derived factor 1, SDF-1) controls many aspects of bone marrow-derived stem cell functions and has been associated with neurogenesis as well with recruitment of brain resident and non-resident circulating cells towards sites of lesion in the central nervous system (CNS). Disrupting this line of chemokine-mediated intercellular communication may contribute to the pathogenesis of Alzheimer's disease (AD). In this study, decreased CXCL12 plasma levels in patients with early AD (p = 0.003) were found, which significantly inversely correlated with CSF tau protein levels (r = -0.373; p = 0.042) and positively with CXCL12 CSF levels (r = 0.429; p = 0.018) and with changes of cognitive functions over the time period of 15 months (r = 0.583; p = 0.009). Our findings indicate a lack of chemotactic activity in early AD and support the view of a deficient regenerative hematopoietic brain support in early AD with putative pathogenic and therapeutic relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700 · cited 1×
“In addition, pathologicalCSF concentrations of A β 1 − 42 and tau protein at baseline have predictive value for the development of AD in patients with mild cognitive impairment [13].”
A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., & Springer, T. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1101 · Cited by 1,482 · cited 1×
“CXCL12 is a potent chemoattractant for T and B lymphocytes, plasma cells, monocytes, and CD34 + hematopoietic progenitor cells and is constitutively expressed in bone marrow-derived stromal cells [2,6].”
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089 · cited 1×
“These data, however, were challenged by recent observationsthat myeloid cells engraftment in the CNS is almost nihil without prior irradiation of the rodent brain [1,27].”
Sunderland, T., Linker, G., Mirza, N., Putnam, K. T., Friedman, D. L., Kimmel, L. H., Bergeson, J., Manetti, G. J., Zimmermann, M., Tang, B., et al. (2003) · JAMA · doi:10.1001/jama.289.16.2094 · Cited by 656
Fiala, M., Liu, Q. N., Sayre, J., Pop, V., Brahmandam, V., Graves, M. C., & Vinters, H. V. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00994.x · Cited by 307 · cited 1×
“A decrease in the abundance of these factors linked to hematopoiesis is particularly noteworthy in light of recent data suggesting that hematopoietic cells and monocytes can enter the brain in AD or in AD mouse models at increased frequencies and modulate the disease [10,36,48].”
Cited by
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 262
Stuart, M. J., & Baune, B. T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.001 · Cited by 259
Advances in the development of new biomarkers for Alzheimer’s disease
Klyucherev, T. O., Olszewski, P., Shalimova, A. A., Chubarev, V. N., Tarasov, V. V., Attwood, M. M., Syvänen, S., & Schiöth, H. B. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00296-z · Cited by 241
“A similar pattern has been observed for interferon gamma-induced protein 10, IL-8 [103], and stromal cell-derived factor-1 [104].”
MethodNeuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.
(2014) · Europe PMC (PubMed Central) · Cited by 177
Role of Chemokines in the Development and Progression of Alzheimer’s Disease
Wojcieszak, J., Kuczyńska, K., & Zawilska, J. B. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02047-1 · Cited by 97
Metadata
- Authors
- Laske, C., Stellos, K., Eschweiler, G. W., Leyhe, T., & Gawaz, M.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2008-08-26
- Volume
- 15
- Issue
- 1
- Pages
- 83-95
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W241141180
- Cited by
- 61
- References
- 6
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreased CXCL12 (SDF-1) Plasma Levels in Early Alzheimer's Disease: A Contribution to a Deficient Hematopoietic Brain Support? https://app.cochat.ai/papers/10.3233/jad-2008-15107
- The paper
- Laske, C., Stellos, K., Eschweiler, G. W., Leyhe, T., & Gawaz, M. (2008). Decreased CXCL12 (SDF-1) Plasma Levels in Early Alzheimer's Disease: A Contribution to a Deficient Hematopoietic Brain Support? Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-2008-15107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.